Profile data is unavailable for this security.
About the company
Sigma Healthcare Limited is an Australia-based company. The principal activities of the Company are the wholesale distribution of pharmaceutical goods and medical consumables to community pharmacies. Its brands include Amcal, Guardian, and Discount Drug Stores. The Company provides a range of solutions, including dispensary services, data and technology, health services, team training, private and exclusive label, sigma rewards, sigma financial services, and supply network and logistics. Its dispensary services provide pharma program, sigma ethical partnership program, and dose administration aid program. Its data and technology provide e-prescription support, health opportunities and sigma performance dashboard tool. Its health services include pharmacy practice support, LEAPP dispensary program, PSS sleep apnoea program and sigma dose administration aid program. Its team training involves sigma online training platform, retail pharmacy programs, and quality care resource hub.
- Revenue in AUD (TTM)3.42bn
- Net income in AUD4.51m
- Incorporated1999
- Employees156.00
- LocationSigma Healthcare LtdLevel 6, 2125 Dandenong Road, ClaytonMELBOURNE 3168AustraliaAUS
- Phone+61 39215-9215
- Fax+61 39215-9188
- Websitehttps://sigmahealthcare.com.au/
Mergers & acquisitions
| Acquired company | SIG:ASX since announced | Transaction value |
|---|---|---|
| CW Group Holdings Ltd | 75.34% | 5.45bn |
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Herbalife Ltd | 7.78bn | 210.32m | 1.33bn | 9.20k | 6.33 | -- | 3.44 | 0.1707 | 1.37 | 1.37 | 50.57 | -- | 1.90 | 2.25 | 58.67 | 551,586.90 | 5.14 | 11.30 | 8.68 | 18.70 | 76.80 | 78.43 | 2.70 | 6.02 | 0.7667 | 2.76 | 1.76 | 0.00 | -2.73 | 0.688 | -55.74 | -13.67 | 9.95 | -- |
| NanJing Pharmaceutical Co Ltd | 11.34bn | 122.32m | 1.35bn | 4.90k | 11.05 | 0.976 | -- | 0.1188 | 0.4397 | 0.4397 | 40.75 | 4.98 | 1.78 | 8.70 | 4.11 | 10,929,970.00 | 2.37 | 2.32 | 8.06 | 8.94 | 5.98 | 6.41 | 1.33 | 1.30 | 1.09 | 2.91 | 0.6148 | 29.82 | 6.71 | 11.35 | -3.00 | 16.93 | -12.67 | 9.86 |
| Neuca SA | 4.49bn | 55.57m | 1.53bn | 5.19k | 28.13 | 4.06 | 14.71 | 0.3412 | 32.42 | 32.42 | 2,617.05 | 224.63 | 2.38 | 7.47 | 7.13 | 2,276,477.00 | 3.21 | 3.58 | 12.45 | 13.31 | 11.07 | 10.33 | 1.35 | 1.43 | 0.4725 | 4.33 | 0.3336 | 34.59 | 5.17 | 8.79 | 6.58 | 8.95 | -3.07 | -- |
| Selcuk Ecza Deposu Ticaret ve Sanayi AS | 4.61bn | 10.53m | 1.54bn | 6.03k | 146.62 | 2.17 | 51.09 | 0.3349 | 0.3594 | 0.3594 | 157.36 | 24.25 | 2.30 | 10.73 | 10.42 | 16,218,930.00 | 0.5255 | 3.16 | 1.41 | 8.40 | 9.38 | 9.37 | 0.2284 | 1.24 | 1.05 | -- | 0.1382 | 27.16 | 14.70 | 48.64 | -64.89 | -10.62 | 23.13 | 20.11 |
| DocMorris AG | 1.62bn | -196.83m | 1.88bn | 1.45k | -- | 2.24 | -- | 1.16 | -10.07 | 7.03 | 83.05 | 36.60 | 0.9863 | 11.36 | 10.50 | 667,214.10 | -11.96 | -12.92 | -15.23 | -15.74 | 20.98 | 16.84 | -12.13 | -10.87 | 1.34 | -2.39 | 0.4448 | -- | 4.13 | -4.29 | 31.29 | -- | -2.53 | -- |
| Guangxi LiuYao Group Co Ltd | 4.50bn | 188.17m | 1.93bn | 5.58k | 9.27 | 1.19 | -- | 0.4279 | 2.46 | 2.46 | 58.82 | 19.12 | 1.07 | 6.99 | 1.97 | 3,807,204.00 | 4.80 | 5.06 | 11.73 | 12.21 | 11.56 | 11.85 | 4.47 | 4.40 | 1.30 | 5.26 | 0.5434 | 29.90 | 9.23 | 12.18 | 21.11 | 9.97 | -8.63 | 6.26 |
| Sigma Healthcare Ltd | 3.42bn | 4.51m | 2.05bn | 156.00 | 317.72 | 2.26 | 60.89 | 0.5993 | 0.004 | 0.004 | 3.34 | 0.5544 | 2.68 | 11.37 | 10.52 | -- | 0.4162 | 0.5734 | 0.625 | 0.9762 | 9.17 | 9.52 | 0.1554 | 0.2022 | 1.86 | 1.59 | 0.1354 | 184.52 | -9.16 | -3.46 | 148.98 | -34.19 | -46.55 | -21.93 |
| Tibet Rhodiola Pharmaceutical Holding Co | 620.61m | 171.61m | 2.50bn | 601.00 | 13.08 | 2.49 | -- | 4.04 | 2.81 | 2.81 | 9.65 | 14.76 | 0.6016 | 1.81 | 6.68 | 4,877,892.00 | 16.83 | 12.44 | 23.18 | 15.71 | 93.68 | 90.51 | 27.97 | 20.43 | 2.79 | 7.96 | 0.1716 | 50.41 | 22.69 | 24.98 | 116.56 | 30.01 | -1.48 | 48.97 |
| GuangYuYuan Chinese Herbal Medicn Co Ltd | 235.24m | -68.68m | 2.66bn | 1.95k | -- | 7.28 | -- | 11.32 | -0.6628 | -0.6628 | 2.27 | 3.53 | 0.4005 | 0.8061 | 1.31 | 569,846.60 | -12.26 | -1.17 | -16.80 | -1.67 | 69.24 | 71.94 | -30.62 | -3.27 | 1.55 | -18.71 | 0.1474 | -- | 16.44 | -3.17 | -26.08 | -- | -50.29 | -- |
| Holder | Shares | % Held |
|---|---|---|
| Paradice Investment Management Pty Ltd.as of 29 Jan 2024 | 71.00m | 4.35% |
| The Vanguard Group, Inc.as of 05 Apr 2024 | 55.43m | 3.40% |
| Allan Gray Australia Pty Ltd.as of 05 Sep 2022 | 54.51m | 3.34% |
| Macquarie Bank Ltd. (Private Banking)as of 05 Sep 2022 | 54.48m | 3.34% |
| Dimensional Fund Advisors LPas of 14 Apr 2023 | 54.48m | 3.34% |
| First Sentier Investors (Australia) IM Ltd.as of 20 Jun 2023 | 54.30m | 3.33% |
| Colonial First State Investments Ltd.as of 12 Oct 2022 | 52.52m | 3.22% |
| First Sentier Investors Realindex Pty Ltd.as of 15 Mar 2023 | 30.24m | 1.85% |
| Wilson Asset Management (International) Pty Ltd.as of 30 Jun 2023 | 28.80m | 1.77% |
| Vanguard Investments Australia Ltd.as of 31 Mar 2024 | 25.60m | 1.57% |
